Harnessing the immune system through programmed death-1 blockade in the management of Hodgkin lymphoma
{{output}}
Immunotherapy is a rapidly evolving therapeutic option in the treatment of lymphoma. Neoplastic cells evade immune recognition through the programmed death (PD)-1/PD-ligand immune checkpoint pathway. Several novel agents have been developed to restore the immu... ...
